[HTML][HTML] How ligand binds to the type 1 insulin-like growth factor receptor

Y Xu, GKW Kong, JG Menting, MB Margetts… - Nature …, 2018 - nature.com
Y Xu, GKW Kong, JG Menting, MB Margetts, CA Delaine, LM Jenkin, VV Kiselyov
Nature communications, 2018nature.com
Human type 1 insulin-like growth factor receptor is a homodimeric receptor tyrosine kinase
that signals into pathways directing normal cellular growth, differentiation and proliferation,
with aberrant signalling implicated in cancer. Insulin-like growth factor binding is understood
to relax conformational restraints within the homodimer, initiating transphosphorylation of the
tyrosine kinase domains. However, no three-dimensional structures exist for the receptor
ectodomain to inform atomic-level understanding of these events. Here, we present crystal …
Abstract
Human type 1 insulin-like growth factor receptor is a homodimeric receptor tyrosine kinase that signals into pathways directing normal cellular growth, differentiation and proliferation, with aberrant signalling implicated in cancer. Insulin-like growth factor binding is understood to relax conformational restraints within the homodimer, initiating transphosphorylation of the tyrosine kinase domains. However, no three-dimensional structures exist for the receptor ectodomain to inform atomic-level understanding of these events. Here, we present crystal structures of the ectodomain in apo form and in complex with insulin-like growth factor I, the latter obtained by crystal soaking. These structures not only provide a wealth of detail of the growth factor interaction with the receptor’s primary ligand-binding site but also indicate that ligand binding separates receptor domains by a mechanism of induced fit. Our findings are of importance to the design of agents targeting IGF-1R and its partner protein, the human insulin receptor.
nature.com